de Lange, Maria ESemmler, AnnikaClark, T JustinMol, Ben Willem JBet, Pierre MHuirne, Judith A FHehenkamp, Wouter J K2024-02-142024-02-142024-02-01de Lange, M E, Semmler, A, Clark, T J, Mol, B W J, Bet, P M, Huirne, J A F & Hehenkamp, W J K 2024, 'Considerations on implementation of the newest treatment for symptomatic uterine fibroids : oral GnRH antagonists', British Journal of Clinical Pharmacology, vol. 90, no. 2, pp. 392-404. https://doi.org/10.1111/bcp.158970306-5251https://hdl.handle.net/2164/2276014729090engelagolixfibroidsleiomyomalinzagolixoral GnRH antagonistrelugolixRG Gynecology and obstetricsRGConsiderations on implementation of the newest treatment for symptomatic uterine fibroids : oral GnRH antagonistsJournal item10.1111/bcp.15897902